Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple Therapy With Vonoprazan, Amoxicillin and Bismuth for Eradication of Helicobacter Pylori
NCT05189444Unknown
- Sponsor
- Huazhong University of Science and Technology
- Start
- Mar 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of vonoprazan in Helicobacter pylori infection (2 arms), sponsored by Huazhong University of Science and Technology. Primary endpoint: Helicobacter pylori eradication at 6 weeks. Status: unknown.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05189444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05189444.